(WBA) Walgreens Boots Alliance - Ratings and Ratios

Walgreens Boots Alliance Inc (NASDAQ:WBA) is a leading healthcare, pharmacy, and retail company with operations in the United States, Germany, the United Kingdom, and other international markets. Established in 1909 and headquartered in Deerfield, Illinois, the company is structured into three key segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment manages a network of retail drugstores, offering a range of services including health and wellness, specialty pharmacy, and home delivery. This segment also provides an assortment of beauty, personal care, and general merchandise products.

Internationally, the company operates under well-known brands such as Boots in the UK, Ireland, Thailand, and Chile, where it is recognized for its pharmacy-led health and beauty retail services. Additionally, it operates under the Benavides brand in Mexico and the Ahumada brand in Chile, offering prescription drugs and consumer products.

The U.S. Healthcare segment focuses on value-based care through VillageMD, which provides primary, specialty, and urgent care services. It also includes Shields, a specialty pharmacy integrator, and CareCentrix, a leader in post-acute and home care management.

Based on technical and fundamental analysis, the 3-month forecast for WBA indicates potential short-term gains due to bullish SMA crossover signals, with price expected to fluctuate between $10.80 and $11.40. However, long-term trends suggest caution due to the stock price hovering below the SMA200 level. The low ATR of 0.17 signals minimal volatility, while the forward P/E of 7.00 and P/S of 0.06 suggest undervaluation. Despite this, the negative RoE of -81.28 may pose challenges.